Oramed Pharmaceuticals Inc. Appoints New Chief Operating Officer and VP of Business Development

Published: Apr 16, 2013

JERUSALEM, April 16, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced a key addition to its executive leadership team with the appointment of Joshua Hexter as Chief Operating Officer and Vice President of Business Development.

Back to news